• Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain 

      Requena, S.; Lozano, A. B.; Caballero, Estrella; García, F.; Nieto, M. C.; Tellez, R.; ...et al.; Soriano, Vicente (1) (Journal of Antimicrobial Chemotherapy, 05/2019)
      Background: HIV-2 is a neglected virus despite estimates of 1-2 million people being infected worldwide. The virus is naturally resistant to some antiretrovirals used to treat HIV-1 and therapeutic options are limited for ...
    • Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain 

      Mendoza, Carmen de; Pirón, María; González, Rocío; Jiménez, Ana; Caballero, Estrella; Roc, Lourdes; Benito, Rafael; Soriano, Vicente (1); Corral, Octavio Jorge (1); ...et al.; Gómez-Gallego, Felix (1) (Open Forum Infectious Diseases, 02/2019)
      Background. Although only 8%-10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late ...
    • HIV co-infection in HTLV-1 carriers in Spain 

      Mendoza, Carmen de; Caballero, Estrella; Aguilera, Antonio; Benito, Rafael; Maciá, Dolores; García-Costa, Juan; Soriano, Vicente (1); Corral, Octavio Jorge (1); Gómez-Gallego, Felix (1); ...et al.; Morano, Luis (Virus Research, 06/2019)
      Background: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. ...
    • Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain 

      Requena, S.; Caballero, Estrella; Lozano, A. B.; Ríos-Villegas, María; Benito, Rafael; Rojo, Silvia; Cabezas, Teresa; Macià, María; Nieto, María del; Soriano, Vicente (1); Mendoza, Carmen de (AIDS, 15/11/2019)
      Background: Whereas HIV-1 has spread globally, HIV-2 is mainly found in West Africa where dual HIV-1/HIV-2 coinfection is nowadays uncommon. Herein, we report the rate, main characteristics, and treatment outcomes of all ...